Johannes van Snick

Mr. Johannes van Snick

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
MRMostafa Roya
Mostafa Roya
SMSamaneh Mostafapour
Samaneh Mostafapour
PMPhilipp Mohr
Philipp Mohr
LPLaura Providência
Laura Providência
ZLZekai Li
Zekai Li
Joyce van SluisJoyce van Sluis
Joyce van Sluis
The latest technical development in the field of positron emission tomography/computed tomography (PET/CT) imaging has been the extension of the PET axial field-of-view. As a result of the increased number of detectors, the long axial field-of-view (LAFOV) PET systems are not only characterized by a larger anatomical coverage but also by a substantially improved sensitivity, compared with conventional short axial field-of-view PET systems. In clinical practice, this innovation has led to the following optimization: (1) improved overall image quality, (2) decreased duration of PET examinations, (3) decreased amount of radioactivity administered to the patient, or (4) a combination of any of the above. In this review, novel applications of LAFOV PET in oncology are highlighted and future directions are discussed.

2 April 2025 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
GSGerbren B. Spoelstra
Gerbren B. Spoelstra
PEPhilip H. Elsinga
Philip H. Elsinga
JDJan Maarten Van Dijl
Jan Maarten Van Dijl
JSJohannes van Snick
Johannes van Snick
BFBen Feringa
Ben Feringa
FIFrank IJpma
Frank IJpma
Purpose: Bacterial infections associated with musculoskeletal injuries are challenging to detect and distinguish from sterile inflammation. Here we present the combined first-time application of a bacteria-targeted positron emission tomography (PET) tracer and a near-infrared fluorescent tracer to detect infected osteosynthesis implants and guide surgical treatment. Methods: To this end, osteosynthesis plates covered with bacterial biofilm and pre-incubated with [18F]PQ-VE1-vancomycin for PET imaging and/or vancomycin-IRDye800CW for optical imaging were fixed to post-mortem human tibiae and femora. PET/CT and fluorescence imaging were used to quantify the bacterial load before and after surgical debridement. Results: Pre-debridement, PET imaging showed a significant 2.2-fold higher tracer uptake on biofilm-covered plates compared to plates without biofilm (p < 0.001). Post-debridement, the PET signal was marginal, demonstrating effective biofilm removal. Fluorescence-guided surgery enabled real-time visualization and removal of bacterial biofilms. Conclusion: Combined preoperative PET and intraoperative fluorescence imaging with vancomycin-based tracers allows noninvasive detection and real-time infection management, as demonstrated by these preliminary findings.

3 August 2024 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
JSJohannes van Snick
Johannes van Snick
KKK P Koopmans
K P Koopmans
AGA W J M Glaudemans
A W J M Glaudemans
GSG N Stormezand
G N Stormezand
OIO V Ivashchenko
O V Ivashchenko

4 November 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
PNPieter H. Nienhuis
Pieter H. Nienhuis
Joyce van SluisJoyce van Sluis
Joyce van Sluis
JSJohannes van Snick
Johannes van Snick
Andor W. J. M. GlaudemansAndor W. J. M. Glaudemans
Andor W. J. M. Glaudemans
SMSofie Meijering
Sofie Meijering
Riemer H.J.A. SlartRiemer H.J.A. Slart
Riemer H.J.A. Slart
The clinical presentation of giant cell arteritis (GCA) is often nonspecific. Differentiating GCA from infectious, malignant, or other autoimmune pathology based on signs, symptoms, and laboratory parameters may therefore be difficult. Fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) imaging is an established tool in the diagnostic workup of GCA. An advantage of 18F-FDG-PET/CT is its ability to assist in the differential diagnosis by being able to demonstrate infection, inflammation, and malignancy when used in conjunction with clinical and laboratory data. Downsides to the use of 18F-FDG-PET/CT include its relatively low spatial resolution, associated radiation exposure, and the relatively long duration of imaging, causing limited availability and patient inconvenience. The advent of long axial field-of-view (LAFOV) PET/CT systems allows for PET imaging at a reduced imaging time or reduced tracer dose while maintaining high image quality. Here, we provide the first reported case of a patient with GCA and polymyalgia rheumatica (PMR) diagnosed using LAFOV PET/CT imaging. The patient presented in this case report had already been experiencing nonspecific symptoms for several years for which no cause was found. Lab investigations showed increased inflammatory parameters as well as persistent anemia. 18F-FDG LAFOV PET/CT attained high-quality images with clear signs of GCA and PMR even at 1 min of scan duration.

4 January 2024 in Frontiers in Medicine
Verified
Journal Article
Open access
JSJohannes van Snick
Johannes van Snick
BLB. van Leer
B. van Leer
MNM. W. N. Nijsten
M. W. N. Nijsten
JPJ. Pillay
J. Pillay
RSR. H. J. A. Slart
R. H. J. A. Slart
NRN. D. van Rijsewijk
N. D. van Rijsewijk
The introduction of new long axial field of view (LAFOV) scanners is a major milestone in positron emission tomography/computed tomography (PET/CT) imaging. With these new systems a revolutionary reduction in scan time can be achieved, concurrently lowering tracer dose. Therefore, PET/CT has come within reach for groups of patients in whom PET/CT previously was undesirable. In this case report we discuss the procedure of a continuous bed motion (CBM) total-body [18F]FDG PET/CT scan in an intensive care patient. We emphasize the clinical and technical possibilities with this new camera system, a matched clinical protocol, and the added value of a dedicated team.

7 October 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
DHDerk ten Hove
Derk ten Hove
Bhanu SinhaBhanu Sinha
Bhanu Sinha
JSJohannes van Snick
Johannes van Snick
Riemer H.J.A. SlartRiemer H.J.A. Slart
Riemer H.J.A. Slart
Andor W. J. M. GlaudemansAndor W. J. M. Glaudemans
Andor W. J. M. Glaudemans
Infective endocarditis (IE) is a serious and diagnostically challenging condition. [18F]FDG PET/CT is valuable for evaluating suspected IE, but it is susceptible to motion-related artefacts. This study investigated the potential benefits of cardiac motion correction for [18F]FDG PET/CT. In this prospective study, patients underwent [18F]FDG PET/CT for suspected IE, combined with a conventional cardiac gating sequence, a data-driven cardiac and respiratory gating sequence (CardioFreezeTM), or both. Scans were performed in adherence to EANM guidelines and assessors were blinded to patients’ clinical contexts. Final diagnosis of IE was established based on multidisciplinary consensus after a minimum of 4 months follow-up and surgical findings, whenever performed. Seven patients participated in the study, undergoing both an ungated [18F] FDG-PET/CT and a scan with either conventional cardiac gating, CardioFreezeTM, or both. Cardiac motion correction improved the interpretability of [18F]FDG PET/CT in four out of five patients with valvular IE lesions, regardless of the method of motion correction used, which was statistically significant by Wilcoxon’s signed rank test: p = 0.046. In one patient the motion-corrected sequence confirmed the diagnosis of endocarditis, which had been missed on non-gated PET. The performance of the two gating sequences was comparable. In conclusion, in this exploratory study, cardiac motion correction of [18F]FDG PET/CT improved the interpretability of [18F]FDG PET/CT. This may improve the sensitivity of PET/CT for suspected IE. Further larger comparative studies are necessary to confirm the additive value of these cardiac motion correction methods.